CA-SEISMIC
6.6.2022 14:02:23 CEST | Business Wire | Press release
Seismic , an apparel company that designs Powered Clothing has launched its newest line in Powered Clothing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220606005336/en/
Seismic Suit for Worker Safety
This is the first Seismic Powered Clothing designed specifically for the Worker Safety market, an over-the-clothes “vest-style” garment inspired by traditional workwear, with a toolbelt form-factor hardware “carrier” at the waist. The Seismic Suit has been deigned in line with OSHA standards and developed in conjunction with teacher customers to protect workers’ core, upper and lower back in repetitive, awkward and hazardous postures. These powered postures include standing, forward lean, backward lean, squatting, stooping, and kneeling.
The Suit automatically senses and responds to the workers movements and delivers powered strength from its 7 twisted string actuators when needed. The Suit has a battery life of up to 10 hours to ensure the worker can complete their shift uninterrupted.
Seismic Suit can deliver 100% sustained powered support, essentially suspending the worker without any muscle engagement.
Seismic Suit is lightweight, breathable, and comfortable with a vest style upper that utilizes the latest materials for cooling and comfort, and a removable belt which houses the battery and drive components so that they can be easily swapped out. Flex-Drive™ muscles are routed within the garment and are aligned with the wearer's anatomical muscles, with quick release connections if they need to be removed. The Suit features an integrated lumbar mechanism, external controls, with haptic and LED feedback. Purpose-built for Manufacturing and Logistics workplace, the Suit doesn’t interfere with existing PPE and can be put on, taken off in less than 60s, laundered for over 50 industrial cycles and serviced quickly to minimize time and associated labor cost. Special design details in the Suits garment pattern, lightweight technical components and low-profile form factor prevent damage when in contact with external products, increase range of motion, and workers agility while performing tasks.
The Seismic Suit for Worker Safety will start shipping in Q1 2023
About Seismic™
Seismic Powered Clothing is a fusion of apparel and robotics, designed to prevent and reduce body strain, fatigue and injury by providing the body's core with extra power and stability. Lightweight, breathable and comfortable - the connected apparel is engineered with patented Flex-Drive™ electric muscles that align with anatomical muscles to provide Intelligent Wearable Strength™.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005336/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FlexTrade Expands Portfolio Risk and Analytics Capabilities Through Strategic Partnership with Portx13.7.2026 15:30:00 CEST | Press release
The collaboration expands FlexTrade’s front-office risk analytics offering, connecting portfolio construction, risk insight, and trading decisions in a unified buy-side workflow. FlexTrade Systems (@FlexTrade), a global leader in multi-asset execution and order management systems, and Portx, an advanced portfolio construction and analytics provider, today announced the integration of Portx’sreal-time portfolio construction, optimization, and risk analytics capabilities into FlexTrade’s integrated buy-side order and execution management system (OEMS), FlexONE. The partnership comes as buy-side firms place greater emphasis on real-time risk management across increasingly complex portfolios, advanced hedging strategies, and supporting operating models. For hedge funds and institutional asset managers, particularly those running multi-strategy or multi-asset approaches, the ability to assess portfolio risk, review pro forma exposures, and act on those insights within the order and executio
Xsolla Connect Returns to Brighton13.7.2026 15:22:00 CEST | Press release
Connecting The UK Game Development Community For Networking And Insights During Develop:Brighton Xsolla, a global video game commerce company, today announced the launch of an exclusive networking event for the UK game development community, Xsolla Connect, taking place with Develop:Brighton 2026 on July 15, 2026. Designed to bring together independent and mid-tier developers, publishers, investors, and industry professionals, the event will offer a focused evening of meaningful connections and actionable insights at one of the UK’s most important annual games gatherings. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713748542/en/ Graphic: Xsolla Develop:Brighton has long served as a cornerstone of the European video games industry, drawing developers, publishers, investors, and studio leaders from across the UK and beyond to share knowledge, explore opportunities, and forge lasting business relationships. Xsolla’s event
Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)13.7.2026 14:32:00 CEST | Press release
Regulatory recognition in the United States and Europe supports the development of NB4168, a novel small molecule candidate for a rare pediatric disease with no approved treatments Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure than conventional NR while maintaining a differentiated pharmacokinetic and safety profile. In addition, the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation (OMPD) to NB4168 for the treatment of A-T, providing regulatory recognition in the European Union and further supporting the Company'
SLB OneSubsea Awarded EPC Contract for Eni’s Baleine Phase 3 Project Offshore Côte d'Ivoire13.7.2026 14:00:00 CEST | Press release
Integrated subsea production system and local capabilities enable accelerated deepwater development Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712734539/en/ SLB OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. Under the contract, SLB OneSubsea will deliver complete subsea production systems (SPS) for 13 wells, reinforcing its role as a core technology and execution partner on one of the most strategically significant offshore developments currently underway in the region. The EPC scope includes subsea trees, um
HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform13.7.2026 14:00:00 CEST | Press release
HistoSonics, today announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713505048/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image guided platform that is intended for the destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors. It uses the mechanical properties of focused ultrasound, called histotripsy, to liquefy and destroy unwanted tissue and tumors in a single procedure without the need for invasive procedures or radiation, and with potentially fewer side effects than traditional therapies. CE Mark approval follows an increasing number of regulatory clearances and was supported by a growing body of clinical ev
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom